News
02-27-2020, 11:31 AM
A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival for patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment.
More... (https://www.news-medical.net/news/20200227/Drug-used-for-breast-renal-cancers-may-provide-survival-benefit-for-patients-with-head-and-neck-cancers.aspx)
More... (https://www.news-medical.net/news/20200227/Drug-used-for-breast-renal-cancers-may-provide-survival-benefit-for-patients-with-head-and-neck-cancers.aspx)